Publicação
Dipeptidyl‐peptidase IV inhibitor‐associated bullous pemphigoid efficiently treated with omalizumab
| dc.contributor.author | Garrido, Pedro | |
| dc.contributor.author | Alexandre, Maria Inês | |
| dc.contributor.author | Travassos, Ana Rita | |
| dc.contributor.author | Filipe, Paulo | |
| dc.date.accessioned | 2021-09-30T11:46:51Z | |
| dc.date.available | 2021-09-30T11:46:51Z | |
| dc.date.issued | 2020 | |
| dc.description | © 2020 Wiley Periodicals LLC. | pt_PT |
| dc.description.abstract | Bullous pemphigoid (BP) is the most common autoimmune blistering disease. High potency topical and/or systemic corticosteroids as well as immunosuppressants are the current mainstay of treatment. However, long-term steroid therapy and systemic immunosuppression may result in significant morbidity and mortality. Contribution of IgE to BP pathogenesis remains under investigation, but increasing evidence supports a pathogenic significance. Omalizumab is a recombinant humanized monoclonal anti-IgE antibody that has recently emerged as a novel promising treatment alternative for BP. | pt_PT |
| dc.description.version | info:eu-repo/semantics/publishedVersion | pt_PT |
| dc.identifier.citation | Dermatol Ther. 2020 Nov;33(6):e14160 | pt_PT |
| dc.identifier.doi | 10.1111/dth.14160 | pt_PT |
| dc.identifier.eissn | 1529-8019 | |
| dc.identifier.issn | 1396-0296 | |
| dc.identifier.uri | http://hdl.handle.net/10451/49720 | |
| dc.language.iso | eng | pt_PT |
| dc.peerreviewed | yes | pt_PT |
| dc.publisher | John Wiley & Sons, Inc. | pt_PT |
| dc.relation.publisherversion | https://onlinelibrary.wiley.com/journal/15298019 | pt_PT |
| dc.title | Dipeptidyl‐peptidase IV inhibitor‐associated bullous pemphigoid efficiently treated with omalizumab | pt_PT |
| dc.type | journal article | |
| dspace.entity.type | Publication | |
| oaire.citation.issue | 6 | pt_PT |
| oaire.citation.title | Dermatologic Therapy | pt_PT |
| oaire.citation.volume | 33 | pt_PT |
| person.familyName | Garrido | |
| person.familyName | Filipe | |
| person.givenName | Pedro | |
| person.givenName | Paulo | |
| person.identifier.ciencia-id | 171A-309C-C397 | |
| person.identifier.orcid | 0000-0002-1048-3056 | |
| person.identifier.orcid | 0000-0002-7337-6493 | |
| person.identifier.scopus-author-id | 7003448874 | |
| rcaap.rights | restrictedAccess | pt_PT |
| rcaap.type | article | pt_PT |
| relation.isAuthorOfPublication | b8bed940-e57b-4d35-a1b2-9ad490e78df5 | |
| relation.isAuthorOfPublication | ac4119d7-4c3c-471a-9723-f8b8e7543f55 | |
| relation.isAuthorOfPublication.latestForDiscovery | b8bed940-e57b-4d35-a1b2-9ad490e78df5 |
Ficheiros
Principais
1 - 1 de 1
Miniatura indisponível
- Nome:
- Dipeptidyl_peptidase.pdf
- Tamanho:
- 45.18 MB
- Formato:
- Adobe Portable Document Format